関連する実験動画
Updated: Jun 13, 2026

10:36
A Swine Model of Neonatal Asphyxia
Published on: October 11, 2011
新生児重症治療室での教育プログラム (SEPREVEN):段階的ケイジ,クラスターランダム化制御試験
Laurence Caeymaex1, Dominique Astruc2, Valérie Biran3
1Neonatal Intensive Care Unit, Centre Hospitalier Intercommunal de Creteil, Creteil, France; Clinical Research Center, Centre Hospitalier Intercommunal de Creteil, Creteil, France; Faculty of Medicine, University Paris Est Creteil, Creteil, France.
Lancet (London, England)
|January 23, 2022
まとめ
新生児集中治療室 (NICU) での有害事象は,新しい教育プログラムによって著しく減少しました. 重症の新生児のケアが改善され 事故率が33%低下しました
科学分野:
- 新生児の集中治療
- 患者の安全
- 医療の質の向上
背景:
- 新生児集中治療室 (NICU) は,高リスクの乳児をケアします.
- 新生児集中治療室では,有害事象は大きな懸念事項です.
- NICUでの有害事象の減少に対する教育介入の影響は依然として過小評価されています.
研究 の 目的:
- NICUでの有害事象を減らすための多面的な教育プログラムの有効性を評価する.
- 重症の新生児に対する安全促進プログラムの影響を評価する.
主な方法:
- フランスにある12のNICUを対象とした多センター,ステップド・ケイジ,クラスターランダム化制御試験.
- 根源的な原因分析とケア・バンドルの教育を含む4ヶ月の多面的なプログラムが実施されました.
- 主なアウトカムは,混合効果のPoissonモデリングを使用して分析された1000患者日あたりの有害事象の発生率でした.
主要な成果:
- 1000患者日あたりの有害事象の発生率 (33. 9 vs 22. 6) が著しく減少した.
- 副作用の発生率比率は0. 67 (95%CI 0. 50- 0. 88; p=0. 0048) であった.
- このプログラムは,全体的な有害事象と,予防可能な重度の有害事象の両方を減少させました.
結論:
- マルチプロフェッショナルな安全促進プログラムにより,脆弱なNICU患者の有害事象が効果的に減少しました.
- この介入によって 重症の新生児のケア品質が 大きく向上する可能性があります
関連する概念動画
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

